Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
08/03/2022* -- Results Q2 2022 -- 2.66 --
08/03/2022* 08:00 EST Earnings Call Q2 2022 -- -- --
05/03/2022 -- Results Q1 2022 2.80 2.34 19.79%
05/03/2022 08:00 EST Earnings Call Q1 2022 -- -- --
02/01/2022 -- Results Q4 2021 3.67 3.49 5.29%
02/01/2022 08:00 EST Earnings Call Q4 2021 -- -- --
11/02/2021 -- Results Q3 2021 2.66 2.36 12.70%
11/02/2021 08:00 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 08/03/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 05/03/2022
Beat/Miss Upgrade
Return Since 3.89%
Last FQE 03/31/2022
Next FQE 06/30/2022

Profile

Edit
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2020, Waters generated 59% from pharmaceutical customers, 30% from industrial clients, and 11% from academic/government institutions.
URL https://www.waters.com
Investor Relations URL https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release Aug. 03, 2022 (est.)
Last Earnings Release May. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 26, 1996

Dividends

Dividend Per Share (TTM) 0.00
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market --
Yield to Sector --
Yield to Industry --
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date Nov. 26, 1996
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
19.39%
-0.14%
43.75%
-2.35%
23.85%
5.89%
50.59%
-8.84%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.97%
3.99%
-33.29%
70.64%
37.27%
10.61%
11.53%
2.82%
-49.26%
12.12%
23.42%
48.01%
-8.71%
40.26%
43.67%
48.92%
-30.74%
--
--
--
--
--
54.43%
18.78%
-40.91%
-58.68%
-88.50%
-99.97%
-99.39%
-89.16%
-15.67%
-56.75%
-49.55%
As of July 05, 2022.

Profile

Edit
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2020, Waters generated 59% from pharmaceutical customers, 30% from industrial clients, and 11% from academic/government institutions.
URL https://www.waters.com
Investor Relations URL https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Blend
Next Earnings Release Aug. 03, 2022 (est.)
Last Earnings Release May. 03, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Nov. 26, 1996

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
PHO 67.89M USD 4.34%
MAW108 116.24M USD 2.48%
CIPMX 164.51M USD 2.44%
NWT088 29.29M USD 2.26%
PXEAX 53.91M USD 2.26%
IBB 159.47M USD 2.05%
ATL774 49.01M USD 2.04%
IHI 126.49M USD 1.91%
RYH 13.88M USD 1.59%
PDP 13.62M USD 1.29%
SUSA 37.82M USD 1.16%
BBGSX 38.36M USD 0.68%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter WAT Tweets